| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.3 |